SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (7334)1/26/2004 11:05:11 AM
From: bio_kruncher  Read Replies (1) of 10280
 
Are "marketing" trial expenses accounted for as R&D? Pharma/biotech companies spend considerable amounts of money funding clinical trials which are really just intended for marketing purposes(i.e. not to fulfill any regulatory requirements for approval or conditions set at approval). I realize there are some grey areas when pursuing label expansion. In light of recent discussions about total SEPR R&D spending, I have been wondering if anybody knows if these marketing type trials are expensed as R&D or Sales&Marketing?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News